advertisement
 

  Back to Current Daily Care News Daily Care News from 2007

Daily Care News from 2007

    30 December 2007

  1. Low discomfort and pain associated with intensified insulin therapy in children and adolescents.
  2. Human Insulin Analog Induced Lipoatrophy.
  3. Comparison between continuous subcutaneous insulin infusion and multiple daily injection regimens in adolescent with type 1 diabetes from a public health care system approach to severe hypoglycemia. Free Portuguese-language full text available in HTML and PDF formats.
  4. Factors influencing pregnancy outcome in women with type 2 versus type 1 diabetes mellitus.
  5. Everyday Walking Linked to Lower Cardiovascular Risk.
  6. Mediterranean-style Eating Staves Off CVD in Diabetes.

    23 December 2007

  7. FreeStyle Navigator(TM) Continuous Glucose Monitoring System Use in Children with Type 1 Diabetes using glargine-based multiple daily dose regimens: Results of a Pilot Trial.
  8. The duration of severe insulin omission is the factor most closely associated with the microvascular complications of Type 1 diabetic females with clinical eating disorders.

    16 December 2007

  9. Insulin Restriction and Associated Morbidity and Mortality in Women with Type 1 Diabetes.
  10. Predictors of good adherence of adolescents with diabetes (insulin-dependent diabetes mellitus).
  11. A standardized protocol to achieve normoglycaemia during labour and delivery in women with type 1 diabetes.
  12. Different Brain Responses To Hypoglycemia Induced By Equipotent Doses Of The Long-acting Insulin Analog Detemir And Human Regular Insulin In Humans.
  13. A randomized cross-over trial to identify the optimal use of insulin glargine in prepubertal children using a three-times daily insulin regimen.
  14. Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.
  15. Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-aged Subjects.
  16. The Association Between Hyperglycemia and Fracture Risk in Middle Age. A prospective, population-based study of 22 444 men and 10 902 women. Free full text available in PDF format.

    9 December 2007

  17. The relationship of A1c to glucose concentrations in children with type 1 diabetes: Assessments by high frequency glucose determinations by sensors.
  18. Impact of glycemic control, disease duration, and exercise on heart rate variability in children with type 1 diabetes mellitus.
  19. Negative binomial meta-regression analysis of combined glycosylated hemoglobin and hypoglycemia outcomes across eleven Phase III and IV studies of insulin glargine compared with neutral protamine Hagedorn insulin in type 1 and type 2 diabetes mellitus concludes that the rate of hypoglycemia is "... significantly lower with glargine than NPH."
  20. Quantifying the Impact of a Short-interval interruption of Insulin-Pump Infusion Sets on Glycemic Excursions.
  21. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients. Free English language full text available in HTML and PDF formats.
  22. Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis.
  23. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.
  24. Hospital admission patterns subsequent to diagnosis of type 1 diabetes in children : a systematic review. Free full text available in PDF format.
  25. Effects of plant stanol esters on serum cholesterol concentrations, relative markers of cholesterol metabolism and endothelial function in type 1 diabetes.
  26. Interventions for being active among individuals with diabetes: a systematic review of the literature.

    2 December 2007

  27. Intensive insulin therapy improves endothelial function and microvascular reactivity in young people with type 1 diabetes.
  28. Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes.
  29. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents.
  30. Mean blood glucose compared with HbA(1c) in the prediction of cardiovascular disease in patients with type 1 diabetes.
  31. Delayed recovery of cognitive function following hypoglycemia in adults with type 1 diabetes: effect of impaired awareness of hypoglycemia.
  32. Trends and Disparities in U.S. Emergency Department Visits for Hypoglycemia, 1993–2005.
  33. Metabolic control and insulin administration in a girl with Turner syndrome and type 1 diabetes during long-term growth hormone therapy.
  34. Dry eye syndrome in diabetic children.
  35. Effective treatment with oral sulfonylureas in patients with diabetes due to SUR1 Mutations.
  36. Factors Affecting Use of Insulin Pens by Patients with Type 2 Diabetes.

    25 November 2007

  37. How far are physical education teachers from elementary school prepared to help pupils with diabetes while they are at school?
  38. NICE backs insulin pump therapy. See Diabetes - insulin pump therapy (Appraisal consultation document).
  39. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
  40. Restoring euglycemia in the Basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.
  41. A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lispro.
  42. Defining the role of insulin detemir in Basal insulin therapy.
  43. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
  44. Gingival bleeding in 6- to 13-year-old children with diabetes mellitus.
  45. Insulin requirement in patients with type 1 diabetes with reduced renal function: a comparison of human and analogue insulin.
  46. Retinal haemodynamics in individuals with well-controlled type 1 diabetes.
  47. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. Free full text available in PDF format.
  48. Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with type 2 diabetes on multiple daily insulin injection therapy.
  49. Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE(TM).

    18 November 2007

  50. The December 2007 issue of the International Journal of Clinical Practice is focused on diabetes, with free full text available for all articles, including:

    1. A call to action – the UN Resolution on diabetes. Free full text also available in PDF format.
    2. United Nations Resolution 61/225 – what does it mean to the diabetes world? Free full text also available in PDF format.
  51. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.
  52. Relationship between glycated haemoglobin levels and mean glucose levels over time.
  53. Relationship between lipid profiles and kidney function in patients with type 1 diabetes.
  54. Self-Monitoring of Blood Glucose Among Adults with Diabetes --- United States, 1997--2006.
  55. Fetal growth in women managed with insulin pump therapy compared to conventional insulin.
  56. Diabetes in pregnancy: a review of current evidence.
  57. Accuracy of Perceptions of Overweight and Relation to Self-Care Behaviors Among Adolescents with Type 2 Diabetes and Their Parents.

    11 November 2007

  58. Continuous subcutaneous insulin infusion therapy: effects on quality of life. Free full text available in PDF format.
  59. A Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion of Insulin Aspart versus Insulin Lispro in Children and Adolescents with Type 1 Diabetes.
  60. Long-term efficacy of insulin.
  61. Real-time continuous glucose monitoring using Guardian((R))RT: from research to clinical practice.
  62. Mediators of Depressive Symptoms in Children with Type 1 Diabetes and their Mothers.
  63. Delayed pubertal onset and development in German children and adolescents with type 1 diabetes: cross-sectional analysis of recent data from the DPV diabetes documentation and quality management system.
  64. Modifications of 24-h blood pressure profile associated with reduction of the heart rate variability in type 1 diabetic patients.
  65. Diabetes mellitus, bone mineral density, and fracture risk.
  66. Carbohydrate nutrition, glycemic index, and the 10-y incidence of cataract.
  67. Diagnosis of neonatal and infancy-onset diabetes.
  68. Management of neonatal and infancy-onset diabetes mellitus.
  69. Not every diabetic child has type 1 diabetes mellitus.
  70. Pancreatic Exocrine Dysfunction in MODY3.

    4 November 2007

  71. Influenza Vaccination: An Unmet Need in Patients With Diabetes.
  72. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
  73. Age-specific Characteristics of the Basal Insulin-rate for Pediatric Patients on CSII.
  74. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
  75. Improving health outcomes among youth with poorly controlled type I diabetes: the role of treatment fidelity in a randomized clinical trial of multisystemic therapy.
  76. Oral health problems in type 1 diabetic children.
  77. Risk factors for coronary disease and stroke in previously hospitalized African-Americans with Type 1 diabetes: a 6-year follow-up.
  78. Self-Monitoring of Blood Glucose Among Adults with Diabetes --- United States, 1997--2006.
  79. Frequency of preeclampsia in pregnant women with type1 diabetes mellitus.
  80. Does Anodyne Light Therapy Improve Peripheral Neuropathy in Diabetes? A Double Blind, Sham Controlled Randomized Trial to Evaluate Monochromatic Infrared Photo Energy.

    28 October 2007

  81. The role of new technologies in treating children and adolescents with type 1 diabetes mellitus.
  82. Combined Insulin Pump Therapy with Real-Time Continuous Glucose Monitoring Significantly Improves Glycemic Control Compared to Multiple Daily Injection Therapy in Pump Naïve Patients with Type 1 Diabetes; Single Center Pilot Study Experience.
  83. Pediatric Quality of Life in Transitioning to the Insulin Pump: Does Prior Regimen Make a Difference?
  84. The Decision Not to Drive During Hypoglycemia in Patients With Type 1 and Type 2 Diabetes According to Hypoglycemia Awareness.
  85. New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus : implications for existing guidelines.
  86. Continuous Glucose Sensors: Continuing Questions about Clinical Accuracy.
  87. Continuous Glucose Profiles in Healthy Subjects under Everyday Life Conditions and after Different Meals.
  88. The Role of Prandial Pramlintide in the Treatment of Adolescents With Type 1 Diabetes.
  89. Pramlintide Improved Glycemic Control and Reduced Weight in Patients With Type 2 Diabetes Using Basal Insulin.
  90. Can we prevent diabetic ketoacidosis in children?
  91. Prerequisites for age-appropriate education in type 1 diabetes: a model programme for paediatric diabetes education in Germany.
  92. Anxiety, depressive, and posttraumatic stress symptoms in mothers of children with type 1 diabetes.
  93. Changes in the Glycemic Profiles of Women With Type 1 and Type 2 Diabetes During Pregnancy.
  94. The effectiveness of insulin initiation regimens in patients with type 2 diabetes mellitus: a large national medical records review study comparing a basal insulin analogue to premixed insulin.
  95. The Effect of Glucosamine on Serum HDL Cholesterol and Apolipoprotein AI Levels in People With Diabetes.

    21 October 2007

  96. Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service.
  97. Telecare for teenagers with type 1 diabetes: a trial.
  98. Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes.
  99. A study of trained clinicians' blood glucose predictions based on diaries of people with type 1 diabetes.
  100. Uncontrolled type 1 diabetes mellitus and endothelial dysfunction in adolescents.
  101. The effect of intense, short-term topical dexamethasone disodium phosphate eyedrops on blood glucose level in diabetic patients.
  102. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
  103. Should pulse pressure and day/night variations in blood pressure be seen as independent risk factors requiring correction or simply as markers to be taken into account when evaluating overall vascular risk?
  104. Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin Therapy. Free full text available in PDF format.
  105. Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: what lessons have we learned from the UKPDS and DCCT studies?
  106. Stakeholder perspectives on the development of a virtual clinic for diabetes care: qualitative study. Free full text available in HTML format.

    14 October 2007

  107. "Being transformed by illness": adolescents' diabetes experience. Free full text available in HTML and PDF formats.
  108. Metabolic control as reflectet by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade.
  109. Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes.
  110. Physical Inactivity Rapidly Induces Insulin Resistance and Microvascular Dysfunction in Healthy Volunteers.
  111. Insulin pump therapy with continuous glucose monitoring improves metabolic control in brittle type 1 diabetes.
  112. The role of the continuous glucose monitoring system in control of the therapy of diabetes.
  113. The effect of insulin glargine and nutritional model on metabolic control, quality of life and behavior in children and adolescents with type 1 diabetes mellitus.
  114. Insulin therapy for patients with type 1 diabetes.
  115. An analysis of the prevalence of thyroid autoantibodies: thyroid peroxidase antibodies (ATA) and thyroglobulin antibodies (ATG) in children with newly diagnosed diabetes mellitus type 1 during 2000-2004 in the Upper Silesia region, Poland.
  116. Advancing Insulin Therapy in Type 2 Diabetes, Previously Treated with Glargine Plus Oral Agents: Prandial Premixed (Lispro/ILPS) vs. Basal/Bolus (Glargine/Lispro) Therapy.
  117. Prevalence of Depression among U.S. Adults with Diabetes: Findings from the 2006 Behavioral Risk Factor Surveillance System.
  118. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities.
  119. Is Glycemic Control Improving in U.S. Adults?
  120. Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 Diabetes Mellitus: a case-report. Free full text available in PDF format.
  121. Low-Grade Inflammation, Obesity and Insulin Resistance in Adolescents. Free full text available in PDF format.

    7 October 2007

  122. Immunological Responses to Exogenous Insulin.
  123. The Effect of Cinnamon on Glucose Control and Lipid Parameters.
  124. Hypoglycemia In Pregnant Women With Type 1 Diabetes: Predictors And Role Of Metabolic Control.
  125. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions.
  126. Families' lived experience one year after a child was diagnosed with type 1 diabetes.
  127. Statins May Benefit Kids With Recalcitrant Lipids.
  128. The effects of vitamin d deficiency and insufficiency on the endocrine and paracrine systems.

    30 September 2007

  129. Continuous glucose monitoring in children with type 1 diabetes.
  130. Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia.
  131. Impact of physical activity on heart rate variability in children with type 1 diabetes.
  132. Identifying the special needs of children with Type 1 diabetes in the school setting. An overview of parents' perceptions.
  133. Approaches to integrating paediatric diabetes care and structured education: experiences from the Families, Adolescents, and Children's Teamwork Study (FACTS).
  134. Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist?
  135. Self-care problems of adolescents with type 1 diabetes in southern Taiwan.
  136. Impaired short-term blood pressure regulation and autonomic dysbalance in children with type 1 diabetes mellitus.
  137. Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Free full text available in PDF format.
  138. Insulin dependant diabetes mellitus: implications for male reproductive function.
  139. Management of type 2 diabetes in youth: an update. Free full text available in HTML and PDF formats.
  140. Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus. Free full text available in PDF format.
  141. Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data.
  142. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
  143. Two styles of acupuncture for treating painful diabetic neuropathy--a pilot randomised control trial.
  144. Actions of insulin beyond glycemic control: a perspective on insulin detemir.

    23 September 2007

  145. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.
  146. Multidimensional study on quality of life in children with type 1 diabetes.
  147. Treatment of type 1 diabetes mellitus revealed below 7 years of age in the Diabetes Center of Silesia, Poland.
  148. Predictors of cognitive impairment in type 1 diabetes.
  149. HbA1c during pregnancy: Its relationship to meal related glycaemia and neonatal birth weight in patients with diabetes.
  150. Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.
  151. Intention to Treat — Initiating Insulin and the 4-T Study. Free full text available in PDF format.
  152. Type 1 diabetes and gastroparesis: diagnosis and treatment.
  153. Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment.

    16 September 2007

  154. One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study.
  155. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
  156. Usefulness of the long-acting insulin analogue glargine in basal-bolus therapy for Japanese children and adolescents with type 1 diabetes mellitus.
  157. Use of insulin glargine during pregnancy.
  158. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
  159. Predicting diabetic ketoacidosis in children by measuring end-tidal CO(2) via non-invasive nasal capnography.
  160. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
  161. Technosphere insulin technology.
  162. Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes.
  163. Inhaled insulin: extending the horizons of inhalation therapy.
  164. Insulin antibodies with pulmonary delivery of insulin.
  165. Autonomic function testing in children and adolescents with diabetes mellitus.
  166. Glycemic effects of moderate alcohol intake among patients with type 2 diabetes: A Multi-center, randomized clinical intervention trial.
  167. The Effect of Aspirin Dosing on Platelet Function in Diabetic and Non-Diabetic Patients: An Analysis from the ASpirin-Induced Platelet EffeCT (ASPECT) Study.

    9 September 2007

  168. Immunologic Responses to Exogenous Insulin. Free full text available in PDF format.
  169. The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation.
  170. 3-Month Results from Denmark within the Globally Prospective and Observational Study to Evaluate Insulin Detemir Treatment in Type 1 and Type 2 Diabetes: The PREDICTIVE Study.
  171. Insulin Pump Therapy During Ramadan Fasting. See also Recommendations for Management of Diabetes During Ramadan.
  172. Adherence behaviours in Taiwanese children and adolescents with type 1 diabetes mellitus.
  173. Delayed menarche in young German women with type 1 diabetes mellitus: recent results from the DPV diabetes documentation and quality management system.
  174. Recruitment to a clinical trial improves glycemic control in patients with diabetes.
  175. Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy.
  176. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).
  177. Bone size normalizes by adolescence in type 1 diabetics references Bone Size Normalizes With Age in Children and Adolescents With Type 1 Diabetes, previously reported.
  178. Antioxidant and Radical Scavenging Activity of Honey in Endothelial Cell Cultures (EA.hy926).

    2 September 2007

  179. Continuing Stability of Center Differences in Pediatric Diabetes Care: Do Advances in Diabetes Treatment Improve Outcome? The Hvidoere Study Group on Childhood Diabetes.
  180. Hyperglycemia and Externalizing Behavior in Children With Type 1 Diabetes.
  181. Influence of flickering light on the retinal vessels in diabetic patients.
  182. Survey on Acute and Chronic Complications in Children and Adolescents With Type 1 Diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania.
  183. The association of early atherosclerosis and retinopathy in adolescents with type 1 diabetes: preliminary report.
  184. Ethnic differences in diabetic retinopathy.
  185. Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus.
  186. LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts.
  187. Associations of Type 1 diabetes mellitus, maternal vascular disease and complications of pregnancy.
  188. Influence of maternal diabetes mellitus on fetal iron status.
  189. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial).
  190. Inhaled Insulin Shows Short-term Safety.
  191. The Rosiglitazone Story — Lessons from an FDA Advisory Committee Meeting. Also available in PDF format.

    19 August 2007

  192. The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI).
  193. Clinical experience in treatment with the long-term insulin analogue glargine in a diabetes centre.
  194. The influence of health threat communication and personality traits on personal models of diabetes in newly diagnosed diabetic patients.
  195. Six-year incidence of visual loss in African Americans with type 1 diabetes mellitus: the New Jersey 725.
  196. Evaluation of inhaled insulin therapy for diabetes mellitus.

    12 August 2007

  197. The Decision not to Drive During Hypoglycemia in Patients with Type 1 and Type 2 Diabetes, According to Hypoglycemia Awareness.
  198. Implantable insulin pumps. A position statement about their clinical use.
  199. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease.
  200. The influence of dietary intake and meal pattern on blood glucose control in children and adolescents using intensive insulin treatment.
  201. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors.
  202. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
  203. Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus.
  204. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
  205. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
  206. Attenuation of amydgala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in Type 1 diabetes: a new player in hypoglycemia unawareness?
  207. Effects of nicardipine-induced hypotension on cerebrovascular carbon dioxide reactivity in patients with diabetes mellitus under sevoflurane anesthesia.
  208. Supplementation of Conventional Therapy with the Novel Grain Salba (Salvia hispanica L.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes: Results of a Randomized Controlled Trial.
  209. The Rosiglitazone Story — Lessons from an FDA Advisory Committee Meeting. Also available in PDF format.

    5 August 2007

  210. Refining basal insulin therapy: what have we learned in the age of analogues?
  211. Self-care In Children With Type 1 Diabetes: A Survey of Mothers.
  212. QT interval prolongation in association with impaired circadian variation of blood pressure and heart rate in adolescents with Type 1 diabetes.
  213. Changes in the glycaemic profiles of women with type 1 and type 2 diabetes during pregnancy.
  214. Masked hypertension in diabetes mellitus: a potential risk.
  215. Diabetic ketoacidosis and cerebral oedema in Sweden-a 2-year paediatric population study.
  216. A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets.

    29 July 2007

  217. Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1 diabetes mellitus.
  218. Proportional Dose-Response Relationship and Lower Within-Patient Variability of Insulin Detemir and NPH Insulin in Subjects With Type 1 Diabetes Mellitus.
  219. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies.
  220. Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus.
  221. The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes.
  222. Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes.
  223. Sliding scale insulin use: myth or insanity?
  224. Prolonged glucose requirements after intentional glargine and aspart overdose.
  225. In First, Do No Harm, Dr. Irl Hirsch cautions about the blanket use of prophylactic ACE inhibitors in patients with no kidney impairment.

    22 July 2007

  226. Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes.
  227. Diets and discipline: the narratives of practice of university students with type 1 diabetes. Free full text available in PDF format.
  228. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study.
  229. Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.
  230. Predicting metabolic control in the first 5 yr after diagnosis for youths with type 1 diabetes: the role of ethnicity and family structure.
  231. The transition to young adulthood in youth with type 1 diabetes on intensive treatment.
  232. The effects of weight status on treatment outcomes in a randomized clinical trial of multisystemic therapy for adolescents with type 1 diabetes and chronically poor metabolic control.
  233. Risk Factors for Mortality in a Diverse Cohort of Patients with Childhood-Onset Diabetes in Chicago.
  234. Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study.
  235. Early treatment with l-thyroxine in children and adolescents with type 1 diabetes, positive thyroid antibodies, and thyroid gland enlargement.
  236. The Relationship of Parental Overprotection, Perceived Child Vulnerability, and Parenting Stress to Uncertainty in Youth with Chronic Illness.
  237. Diabetes and Tooth Loss in a National Sample of Dentate Adults Reporting Annual Dental Visits.
  238. Depression is a Risk Factor for Poor Glycemic Control and Retinopathy in African-Americans With Type 1 Diabetes.
  239. Interventions for latent autoimmune diabetes (LADA) in adults.

    15 July 2007

  240. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study.
  241. Prevalence of diabetic retinopathy in children and adolescents with type-1 diabetes attending summer camps in France.
  242. Post-exercise microalbuminuria in newly diagnosed type 1 diabetic children - preliminary report.
  243. Helicobacter pylori infection and its metabolic consequences in children and adolescents with type 1 diabetes mellitus.
  244. Diabetes Personal Trainer Outcomes: Short-term and One-year Outcomes of a "Diabetes Personal Trainer" Intervention among Youth with Type I Diabetes.
  245. Assessing treatment satisfaction in patients treated with pramlintide as an adjunct to insulin therapy.
  246. Vitreous hemorrhage in diabetic eyes previously treated with panretinal photocoagulation.
  247. Accuracy of filter paper method for measuring glycated hemoglobin.

    8 July 2007

  248. Glycemic control over 3 years in a young adult clinic for patients with type 1 diabetes.
  249. Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin.
  250. Use of insulin glargine in Japanese patients with type 1 diabetes. Free full text available in PDF format.
  251. Incorporating PDA Use in Diabetes Self-Care: A Central Texas Primary Care Research Network (CenTexNet) Study. Free full text available in HTML and PDF formats.
  252. Experiences of patients with insulin-treated diabetes in conscript military service.
  253. Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes.
  254. Severe complications of a "Brazilian" bikini wax.
  255. Profile of diabetes health care at Benghazi Diabetes Centre, Libyan Arab Jamahiriya.
  256. Heart transplantation in insulin-treated diabetic mellitus patients with diabetes-related complications.

    1 July 2007

  257. Awakening and Counterregulatory Response to Hypoglycemia During Early and Late Sleep.
  258. A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes.
  259. The Use of Continuous Subcutaneous Insulin Infusion (CSII): Parental and Professional Perceptions of Self-care Mastery and Autonomy in Children and Adolescents.
  260. Evaluation of periodontal status in young patients with insulin-dependent diabetes mellitus (type 1).
  261. Child and parental personality are associated with glycaemic control in Type 1 diabetes.
  262. Differing Causes of Pregnancy Loss in Type 1 and Type 2 Diabetes.
  263. Six-Year Incidence of Proteinuria in Type 1 Diabetic African Americans.
  264. AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease.

    24 June 2007

  265. Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy.
  266. Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture.

    17 June 2007

  267. Glucose concentration can be predicted ahead in time from continuous glucose monitoring sensor time-series.
  268. Assessing glycemia in type 1 diabetic patients using a microdialysis system for continuous glucose monitoring.
  269. Mortality and diabetes from a population based register in Yorkshire 1978-93. Free full text available in HTML and PDF formats.
  270. Physical activity and sports participation in children and adolescents with type 1 diabetes mellitus.
  271. Fertility in women with type 1 diabetes mellitus. A population-based cohort study in Sweden.
  272. Mother-Child Appraised Involvement in Coping with Diabetes Stressors and Emotional Adjustment.
  273. Unmitigated communion and health among adolescents with and without diabetes: the mediating role of eating disturbances.
  274. Hyperglycaemia and externalising behaviour in children with type 1 diabetes.
  275. Why do adolescents with type 1 diabetes and their parents participate in focus groups?
  276. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
  277. Could we predict asymptomatic cardiovascular autonomic neuropathy in type 1 diabetic patients attending out-patients clinics?
  278. "Sir Insulin Monk Versus the Evil Diana Betes": A Program Addressing Type 2 Diabetes Education and Prevention in Youth. See also Diabetes Education and Prevention in Youth and the online video (Real Player required).
  279. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes. Free full text available in HTML and PDF formats. See also Rosiglitazone and Cardiovascular Risk.

    10 June 2007

  280. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy.
  281. Glycaemic control and hypoglycaemia in children, adolescents and young adults with unstable type 1 diabetes mellitus treated with insulin glargine or intermediate-acting insulin.
  282. Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.
  283. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children.
  284. An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment.
  285. Diabetes mellitus and risk of endometrial cancer: a meta-analysis.
  286. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects.
  287. Screening for Addison's disease in patients with type 1 diabetes mellitus and recurrent hypoglycaemia.
  288. Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis appears to contradict earlier reports of increased cardiovascular effects. Free full text available in HTML and PDF formats. See also Rosiglitazone — Continued Uncertainty about Safety, Rosiglitazone and Cardiotoxicity — Weighing the Evidence, and The Record on Rosiglitazone and the Risk of Myocardial Infarction.

    3 June 2007

  289. Insulin aspart : an evidence-based medicine review.
  290. Glargine versus NPH insulin: Efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes-The glargine and aspart study (GLASS) A randomised cross-over study.
  291. Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms using insulin glargine.
  292. A review of human and analogue insulin trials.
  293. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
  294. A transition care programme which improves diabetes control and reduces hospital admission rates in young adults with Type 1 diabetes aged 15-25 years.
  295. Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia.
  296. Outcomes of pregnancies affected by impaired glucose tolerance.
  297. Safety and tolerability of acarbose in the treatment of type 1 and type 2 diabetes mellitus.
  298. Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study.
  299. The Perfect Storm—Drug Safety And Rosiglitazone is an editorial by Richard Hellman, MD, FACP, FACE, and was published in the the May/June edition of the journal Endocrine Practice.

    27 May 2007

  300. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes. Free full text available in HTML and PDF formats. See also Rosiglitazone and Cardiovascular Risk; FDA Issues Safety Alert on Avandia; Rosiglitazone: seeking a balanced perspective, an editorial from The Lancet; GlaxoSmithKline Responds to NEJM Article on Avandia, and Avandia Update from GSK.
  301. Prediction of Severe Hypoglycemia.
  302. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus.
  303. Concomitant Reduction of LDL-Cholesterol and Biomarkers of Inflammation with Low Dose Simvastatin Therapy in Patients with Type 1 Diabetes. Free full text available in PDF format.
  304. The prevalence of cutaneous manifestations in young patients with IDDM.
  305. Oral health status and dental service needs of diabetic patients.
  306. Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases.
  307. Objectively Measured Light-Intensity Physical Activity Is Independently Associated With 2-h Plasma Glucose.
  308. Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new onset type 1 diabetes. Free full text available in PDF format.
  309. Young women with diabetes: using Internet communication to create stability during life transitions.
  310. Interindividual Variability and Intra-Individual Reproducibility of Glycemic Index Values for Commercial White Bread.
  311. Relationship of Physician Volume With Process Measures and Outcomes in Diabetes.
  312. Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes.
  313. Carbonated Beverages and Chronic Kidney Disease.

    20 May 2007

  314. Type 1 diabetes: exercise and hypoglycemia.
  315. Responses to acute exercise in type 2 diabetes, with an emphasis on metabolism and interaction with oral hypoglycemic agents and food intake.
  316. Physical activity and psychological well-being in children with Type 1 diabetes.
  317. Impact of hypoglecemic episodes on nerves conduction and auditory and visual evoked potentials in children with type 1 diabetes.
  318. Diabetes mellitus promotes periodontal destruction in children.
  319. Psychiatric co-morbidity & diabetes. Free full text available in PDF format.
  320. Juggling type 1 diabetes and pregnancy in rural Australia.
  321. Smoking behavior during pregnancy of women with type 1 or gestational diabetes.
  322. Osteoporosis in Patients with Diabetes Mellitus.
  323. Epidemiological studies of exercise in diabetes prevention.

    13 May 2007

  324. Body composition in young female adults with Type 1 diabetes mellitus. A prospective case-control study.

    6 May 2007

  325. Long-Term Effect of Diabetes and Its Treatment on Cognitive Function. See also Intense Diabetes Therapy OK for Brain; Tight Control of Type 1 Diabetes Poses No Risk to Mental Skills and Tight Diabetes Control Does not Impact Cognitive Ability in Type 1 Diabetes.
  326. Early retinopathy progression in four randomized trials comparing insulin glargine and NPH insulin.
  327. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
  328. Adolescents' experience of living with diabetes.
  329. Six-year incidence of proteinuria in type 1 diabetic African-Americans.
  330. Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes.
  331. Diabetes mellitus and risk of endometrial cancer: a meta-analysis.
  332. Relationships and their potential for change developed in difficult type 1 diabetes.
  333. Prescription of insulin glargine in primary care practices in Germany.
  334. Short-Term Risk for Stroke Is Doubled in Persons With Newly Treated Type 2 Diabetes Compared With Persons Without Diabetes. A Population-Based Cohort Study.
  335. Moderate alcohol consumption and insulin sensitivity: observations and possible mechanisms.
  336. Pharmacokinetics of an Oral Drug (Acetaminophen) Administered at Various Times Relative to Subcutaneous Injection of Pramlintide in Subjects With Type 2 Diabetes.
  337. Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues.

    29 April 2007

  338. Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System. Free full text available in HTML and PDF formats.
  339. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia.
  340. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
  341. Hypoglycemia during sleep impairs consolidation of declarative memory in type 1 diabetic and healthy humans.
  342. The current issue of Clinical Diabetes has several articles about insulin pump therapy, including:

    1. Is There a Place for Insulin Pump Therapy in Your Practice? Free full text available in PDF format.
    2. Insulin Pumps. Free full text available in PDF format.
  343. The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
  344. Changes in glycaemic control are related to the systolic function in type 1 diabetes mellitus.
  345. Bone size normalizes with age in children and adolescents with Type 1 diabetes mellitus.
  346. Prandial Insulin Dosing Using Run-to-Run Control.
  347. Identification of Distinct Self-Management Styles of Adolescents With Type 1 Diabetes.
  348. Assessment of an empowerment education programme. A randomized study in teenagers with diabetes.
  349. Increased Second Trimester Maternal Glucose Levels Are Related to Extremely Large-for-Gestational-Age Infants in Women With Type 1 Diabetes.
  350. High-Viscosity Hydroxypropylmethylcellulose Blunts Postprandial Glucose and Insulin Responses.
  351. Health outcomes for diabetes patients returning for three annual general practice checks.
  352. Using Continuous Glucose Monitoring to Measure the Frequency of Low Glucose Values When Using Biphasic Insulin Aspart 30 Compared With Biphasic Human Insulin 30; A double-blind crossover study in individuals with type 2 diabetes.
  353. Evaluation of Inaccuracies in the Measurement of Glycemia in the Laboratory, by Glucose Meters, and Through Measurement of Hemoglobin A1c.
  354. Microvascular Complications in Cystic Fibrosis–Related Diabetes.

    22 April 2007

  355. Fasting c-peptide and insulin-like growth factor-binding protein-1 levels help to distinguish childhood type 1 and type 2 diabetes at diagnosis.
  356. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus.
  357. Use of Maternal Glycosylated Hemoglobin Concentration to Estimate the Risk of Congenital Anomalies in the Offspring of Women with Pre-Pregnancy Diabetes Mellitus.
  358. A multicenter Italian study on pregnancy outcome in women with diabetes.
  359. Role of physical exercise in children and adolescents with diabetes mellitus.
  360. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test.
  361. Transformational experience of a student nurse with diabetes: a case study.
  362. Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital.
  363. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.
  364. A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.

    15 April 2007

  365. Seeking the Factors Predisposing to Local Skin Inflammatory State Development in Children with Type 1 Diabetes (T1DM) Treated with Continuous Subcutaneous Insulin Infusion (CSII).
  366. The Role of Parental Monitoring in Adolescent Health Outcomes: Impact on Regimen Adherence in Youth with Type 1 Diabetes.
  367. Long-term Improvement of Metabolic Control Without Increased Risk of Hypoglycaemia by Intensive Insulin Regimens in Type 1 Diabetes Patients Treated in a Regular Clinical Setting.
  368. Menstrual Cycle Effects on Insulin Sensitivity in Women with Type 1 Diabetes: A Pilot Study.
  369. New technology, new errors: how to prime an upgrade of an insulin infusion pump.
  370. Blood glucose and ketone monitoring in type 1 diabetic patients in the controlled environment of a summer camp.
  371. Progression of retinopathy during pregnancy in type 1 diabetes mellitus.

    8 April 2007

  372. An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK.
  373. Short acting insulin analogues for treating diabetic patients with CSII (continuous subcutaneous insulin infusion).
  374. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
  375. Tricyclic antidepressants for chronic vomiting in diabetic patients.
  376. Management of diabetic ketoacidosis in a teaching hospital.
  377. Breastfeeding habits in families with Type 1 diabetes.
  378. The evidence base for the efficacy of antibiotic prophylaxis in dental practice.
  379. Sliding (Scale) Down a Slippery Slope? Go to Proactive Glycemic Control in Patients.
  380. Quality of Diabetes Care Among Adults With Serious Mental Illness.
  381. The role of physical activity in the management of impaired glucose tolerance: a systematic review.

    1 April 2007

  382. Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy.
  383. PREDICTIVE™- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.
  384. Impact of breast-feeding on psychomotor and neuropsychological development in children of diabetic mothers: role of the late neonatal period.
  385. Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control.
  386. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
  387. Plasma glucagon decreases during night-time sleep in Type 1 diabetic patients and healthy control subjects.
  388. Ketoacidosis at Diagnosis of Type 1 Diabetes in Children in Northern Finland.
  389. DKA, CVL and DVT. Increased risk of deep venous thrombosis in children with diabetic ketoacidosis and femoral central venous lines.
  390. Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia.
  391. Relationship between markers of metabolic control and inflammation on severity of periodontal disease in patients with diabetes mellitus.
  392. The Effect of Cinnamon on A1C Among Adolescents With Type 1 Diabetes.
  393. Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy; A randomized trial of insulin aspart versus human insulin in 322 pregnant women.
  394. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA(1c) predicts dyslipidaemia.
  395. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.
  396. The influence of diabetes upon adolescent and young adult development: a qualitative study.
  397. A 6-Month, Randomized, Double-Masked, Placebo-Controlled Study Evaluating the Effects of the Protein Kinase C-ß Inhibitor Ruboxistaurin on Skin Microvascular Blood Flow and Other Measures of Diabetic Peripheral Neuropathy.
  398. Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

    25 March 2007

  399. Strong association between time watching television and blood glucose control in children and adolescents with type-1 diabetes mellitus.
  400. Association of glucose levels and glucose variability with mood in type 1 diabetic patients.
  401. Severe Hypoglycemia and Smoking in a Long-Term Type 1 Diabetic Population: Wisconsin Epidemiologic Study of Diabetic Retinopathy.
  402. Type 1 diabetes and prolonged fasting.
  403. Insulin detemir in the treatment of type 1 and type 2 diabetes.
  404. Insulin glargine in the treatment of type 1 and type 2 diabetes.
  405. Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetes.
  406. Co-morbidity, functionality and time since diagnosis as predictors of physical activity in individuals with type 1 or type 2 diabetes.
  407. Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade.
  408. Age of onset of type 1 diabetes in children and carotid intima medial thickness. Free full text available in PDF format.
  409. Assessment of an empowerment education programme. A randomized study in teenagers with diabetes.
  410. Updated and Revised Diabetes Family Conflict Scale.
  411. A controlled study of psychosocial factors in young people with diabetes in the United Arab Emirates.
  412. Technologies, diabetes and the student body.
  413. Birth weight and maternal glycated haemoglobin in pregnancies complicated by type 1 diabetes.
  414. Diabetes Hospitalization at the U.S.–Mexico Border.

    18 March 2007

  415. Prediction of severe hypoglycemia.
  416. Safe at School; A Virginia Experience.
  417. Insulin glargine in intensively-treated type 1 diabetes mellitus. Free Spanish language full text available in HTML and PDF formats.
  418. A multi-centre randomised controlled trial of motivational interviewing in teenagers with diabetes.
  419. Young women with diabetes: using Internet communication to create stability during life transitions.
  420. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
  421. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes.
  422. Evaluation of treatment adherence in type 1 diabetes: a novel approach.
  423. Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes.
  424. Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes.

    11 March 2007

  425. Accuracy of the 5-day FreeStyle Navigator® Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements.
  426. What is the frequency of symptomatic mild hypoglycemia in type 1 diabetes in the young?: assessment by novel mobile phone technology and computer-based interviewing.
  427. Satisfaction and Quality of Life with Premeal Inhaled versus Injected Insulin in Adolescents and Adults with Type 1 Diabetes.
  428. Evolution of a Pulmonary Insulin Delivery System (Exubera) for Patients With Diabetes.
  429. Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada.
  430. Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK.
  431. The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis.
  432. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes.
  433. Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes.

    4 March 2007

  434. Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus. Free full text available in PDF format.
  435. Awakening from Sleep and Hypoglycemia in Type 1 Diabetes Mellitus. Free full text available in PDF format.
  436. The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes.
  437. Classification of Distinct Baseline Insulin Infusion Patterns in Children and Adolescents With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy.
  438. Perceptions of Psychosocial Factors and the Insulin Pump.
  439. Decision-Making Competence and Adherence to Treatment in Adolescents with Diabetes.
  440. School performance in children with type 1 diabetes-a population-based register study.
  441. Brief Report: The Risk of Posttraumatic Stress Disorder in Mothers of Children Diagnosed with Pediatric Cancer and Type I Diabetes.
  442. Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes.
  443. Two-Year Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 1 Diabetes.
  444. Randomized Trial of Behavioral Family Systems Therapy for Diabetes - Maintenance of effects on diabetes outcomes in adolescents.
  445. The Impact of Glycemic Control on Neonatal Outcome in Singleton Pregnancies Complicated by Gestational Diabetes.
  446. Does Dairy Calcium Intake Enhance Weight Loss Among Overweight Diabetic Patients?

    25 February 2007

  447. Self-report and parent-report of physical and psychosocial well-being in Dutch adolescents with type 1 diabetes in relation to glycemic control. Free full text available in HTML and PDF formats.
  448. Hyperglycemic crises and their complications in children.
  449. Long-term use of continuous subcutaneous insulin infusion compared with multiple daily injections of glargine in pediatric patients.
  450. Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomes.
  451. Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.
  452. Outside-hospital assistance for children and adolescents with type 1 diabetes mellitus.
  453. Diabetes Nutrition and Complications Trial: adherence to the ADA nutritional recommendations, targets of metabolic control, and onset of diabetes complications. A 7-year, prospective, population-based, observational multicenter study.
  454. Medical Costs of Diabetic Complications Total Costs and Excess Costs by Age and Type of Treatment Results of the German CoDiM Study.
  455. An unusual cause of severe hypoglycaemia in type 1 diabetes mellitus. Antepartum pituitary failure: a case report and literature review.

    18 February 2007

  456. Injection of acidic or neutral insulin and pain: A single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
  457. Implantable insulin pumps. A position statement about their clinical use.
  458. Natural history and predictors of disturbed eating behaviour in girls with Type 1 diabetes.
  459. Characteristics of depressiveness among adolescents with diabetes mellitus.
  460. Multisystemic therapy for adolescents with poorly controlled type I diabetes: stability of treatment effects in a randomized controlled trial.
  461. Chromium treatment has no effect in Patients with Type 2 Diabetes Mellitus in a Western Population: A Randomized, Double-Blind, Placebo-Controlled Trial.

    11 February 2007

  462. The role of friendship in the lives of male and female adolescents: does diabetes make a difference?
  463. Metabolic control with insulin pump therapy: the Waikato experience.
  464. Comparison of dinner with bedtime administration of insulin glargine in type 1 diabetic patients treated with basal-bolus regimen.
  465. Clinical picture at the onset of type 1 diabetes mellitus in children.
  466. Predictors of treatment adherence in young children with type 1 diabetes.
  467. Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus.
  468. Serum Lipids and Glucose Control: The SEARCH for Diabetes in Youth Study.
  469. Systematic screening for diabetic retinopathy with a digital fundus camera following pupillary dilatation in a university diabetes department.
  470. A Communication Platform for Tele-monitoring and Tele-management of Type 1 Diabetes.
  471. Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes.
  472. Incretins and other peptides in the treatment of diabetes.
  473. Diets and discipline: the narratives of practice of university students with type 1 diabetes.
  474. Hyperandrogenism and Polycystic Ovary Syndrome (PCOS) in Women with Type 1 Diabetes Mellitus. Free full text available in PDF format.
  475. Diabetes and C-Reactive Protein. Free full text available in PDF format.
  476. Circulating Antipericyte Autoantibodies: A Novel Modifier of Risk of Progression of Diabetic Retinopathy?
  477. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy.

    4 February 2007

  478. Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with Type 1 diabetes.
  479. Maternal Trait Anxiety and Diabetes Control in Adolescents with Type 1 Diabetes.
  480. Ethnic differences in the timely diagnosis of children with Type 1 diabetes mellitus in the Netherlands: clinical presentation at onset.
  481. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.

    28 January 2007

  482. Effect of Adjunctive Pramlintide Treatment on Treatment Satisfaction in Patients With Type 1 Diabetes.
  483. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump.
  484. The usage of the personal insulin pump for treatment of a 7 week infant with neonatal diabetes mellitus.
  485. Prehypertension in type 1 diabetic children and adolescents.
  486. Longitudinal lipid screening and use of lipid-lowering medications in pediatric type 1 diabetes.
  487. Misperceptions regarding influenza vaccine safety for individuals with chronic medical illness.
  488. The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes.
  489. Physical Activity in U.S. Adults With Diabetes and At Risk for Developing Diabetes, 2003.
  490. Physical Activity and Metabolic Risk in Individuals With a Family History of Type 2 Diabetes.
  491. Retinopathy Predicts Cardiovascular Mortality in Type 2 Diabetic Men and Women.
  492. Effect of Periodontitis on Overt Nephropathy and End-Stage Renal Disease in Type 2 Diabetes.
  493. History of major depressive disorder and diabetes outcomes in diet- and tablet-treated post-menopausal women: a case control study.
  494. Microvascular breast reconstruction in the diabetic patient.
  495. Antioxidants and CVD in Diabetes: Where Do We Stand Now.

    21 January 2007

  496. Caring for young adults with diabetes. Also available in PDF format. See also The Maestro Project.
  497. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.
  498. Admissions for diabetic ketoacidosis in ethnic minority groups in a city hospital.
  499. Bone mineral density and hip structural analysis in type 1 diabetic men.
  500. Metabolic control and nocturnal enuresis in children with type 1 diabetes.
  501. Family influence on self-care, quality of life, and metabolic control in school-age children and adolescents with type 1 diabetes.
  502. Pre-eclampsia but not pregnancy-induced hypertension is a risk factor for diabetic nephropathy in type 1 diabetic women.
  503. Physiological effects of exercise training in patients with type 1 diabetes. Free Portuguese-language full text available in HTML and PDF formats.
  504. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Free full text available in HTML and PDF formats.
  505. Managing diabetes care using an integrated regional e-health approach.
  506. Telemedicine for diabetes support in family doctors' practices: a pilot project.
  507. The effect of the holiday season on body weight and composition in college students. Free full text available in HTML and PDF formats.
  508. New fat, same old problem with an added twist? See also Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans, also available in PDF format.

    14 January 2007

  509. Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.
  510. Aspart and lispro insulin, is there any difference when used with an insulin pump treatment?
  511. The development of an innovative education curriculum for 11-16 yr old children with type 1 diabetes mellitus (T1DM).
  512. What Adolescents With Type I Diabetes and Their Parents Want From Testing Technology: A Qualitative Study.
  513. Adjunctive therapy with pramlintide in patients with type 1 or type 2 diabetes mellitus.

    7 January 2007

  514. Dietary adherence and associated glycemic control in families of young children with type 1 diabetes.
  515. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being.
  516. Cost-effectiveness of Systematic Depression Treatment Among People With Diabetes Mellitus.
  517. Sleep and metabolic control: waking to a problem?
  518. Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients.

[ Current Daily Care News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Home Return to Top

Last Updated: Thursday January 01, 2015 15:28:57
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.